Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Andraž Perhavec) .

11 - 20 / 28
First pagePrevious page123Next pageLast page
11.
Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia
Taja Ložar, Janez Žgajnar, Andraž Perhavec, Ana Blatnik, Srdjan Novaković, Mateja Krajc, 2021, original scientific article

Abstract: Objectives. Risk-reducing mastectomy (RRM) is one of key prevention strategies in female carriers of germline BRCA pathogenic/likely pathogenic variants (PV/LPV). We retrospectively investigated the rate, timing and longitudinal trends of bilateral RRM uptake and the incidence and types of cancers among unaffected BRCA carriers who underwent genetic counseling at the Institute of Oncology Ljubljana in Slovenia. Materials and Methods. Female BRCA carriers without personal history of cancer were included in the study. Clinical data on PV/LPV type, date of RRM, type of reconstructive procedure, occult carcinoma and histopathology results was collected and analyzed. Results. Of the 346 unaffected BRCA carriers (median age 43 years, 70% BRCA1, 30% BRCA2, median follow-up 46 months) who underwent genetic testing between October 1999 and December 2019, 25.1% had a RRM (range 35-50 years, median age at surgery 38 years). A significant difference in time to prophylactic surgery between women undergoing RRM only vs. women undergoing RRM combined with risk-reducing salpingo-oophorectomy was observed (22.6 vs 8.7 months, p=0.0009). We observed an upward trend in the annual uptake in line with the previously observed Angelina Jolie effect. In 5.7% of cases, occult breast cancer was detected. No women developed breast cancer after RRM. Women who did not opt for surgical prevention developed BRCA1/2-related cancers (9.3%). Conclusion. The uptake of RRM among unaffected BRCA carriers is 25.1% and is similar to our neighboring countries. No women developed breast cancer after RRM while women who did not opt for surgical prevention developed BRCA1/2 related cancers in 9.3% of cases. The reported data may provide meaningful aid for carriers when deciding on an optimal prevention strategy.
Keywords: risk-reducing mastectomy, breast cancer, BRCA
Published in DiRROS: 21.09.2022; Views: 432; Downloads: 147
.pdf Full text (593,94 KB)

12.
13.
Kirurško zdravljenje, kje ima mesto v prihodnosti
Andraž Perhavec, 2021, published scientific conference contribution

Keywords: kirurško zdravljenje, sistemsko zdravljenje, onkološko zdravljenje
Published in DiRROS: 24.03.2022; Views: 429; Downloads: 233
.pdf Full text (332,40 KB)
This document has many files! More...

14.
15.
Rak jajčnikov : česa še ne vemo? : ginekološki simpozij : Ljubljana, 2. 12. 2021 : zbornik znanstvenih prispevkov
2021, proceedings of professional or unreviewed scientific conference contributions

Abstract: Ginekološki simpozij Rak Jajčnika: Česa še ne vemo? zajema sklop predavanj, kjer so predstavljeni začetna obravnava žensk s tumorji v področju jajčnikov, nadaljnja predoperativna priprava, najradikalnejši kirurški posegi in zadnje smernice na področju sistemske terapije. Prav tako pozornost namenjamo tudi stereotaktičnemu obsevanju in imunoterapiji, ki na področju ginekoloških rakov počasi dobiva svojo veljavo in mesto.
Keywords: napredovali rak, mejno maligni tumorji, ekstraabdominalna kirurgija, citoredukcija, bevacizumab, polimorbidnost, stereotaktično obsevanje, imunoterapija, zborniki, elektronske knjige
Published in DiRROS: 10.03.2022; Views: 721; Downloads: 342
.pdf Full text (1,31 MB)
This document has many files! More...

16.
17.
18.
Sledenje bolnic z rakom dojk
Andraž Perhavec, 2019, published professional conference contribution

Keywords: rak dojk, sledenje bolnic, register raka
Published in DiRROS: 20.05.2020; Views: 1614; Downloads: 478
.pdf Full text (54,44 KB)

19.
Sledenje bolnic z rakom dojk
Andraž Perhavec, 2016, published professional conference contribution

Keywords: ponovitve bolezni, rak dojke, bolniki, sledenje
Published in DiRROS: 20.05.2020; Views: 1612; Downloads: 474
.pdf Full text (54,36 KB)

20.
Sledenje po končanem zdravljenju, preživetje v Sloveniji
Andraž Perhavec, 2018, published scientific conference contribution

Keywords: maligni tumorj kosti, maligni tumorji mehkih tkiv, preživetje
Published in DiRROS: 08.05.2020; Views: 1760; Downloads: 582
.pdf Full text (71,16 KB)

Search done in 0.32 sec.
Back to top